- The European Committee for Medicinal Products for Human Use (CHMP) has recommended approving Kostaive, a self-replicating mRNA (saRNA) vaccine, despite significant safety concerns and lack of long-term data.
- Kostaive introduces a novel mechanism where injected mRNA replicates within the body, similar to a viral infection, potentially causing unknown long-term effects and raising ethical concerns about bodily autonomy.
- Kostaive trials showed high adverse event rates, with 90% of participants experiencing side effects, 74.5% reporting systemic reactions, and 15.2% requiring medical attention. Five deaths were reported in the phase 3b study.
- There is no long-term research on the potential risks of saRNA vaccines, including the possibility of cancerous mutations, autoimmune responses, or other harmful effects.
- Approval of Kostaive could set a dangerous precedent, prioritizing corporate profits over public safety and undermining health freedom, transparency, and democratic governance.
The recent recommendation by the European Committee for Medicinal Products for Human Use (CHMP) to approve Kostaive, a self-replicating mRNA (saRNA) vaccine, marks a troubling escalation in the pharmaceutical industry’s push to deploy untested and potentially hazardous technologies on the global population. This decision, which now rests with the European Commission, raises serious concerns about the erosion of health freedom, government transparency, and the prioritization of corporate profits over public safety.
Self-replicating mRNA vaccines, such as Kostaive, are not merely another iteration of traditional mRNA technology. They represent a radical departure from conventional vaccines, introducing a mechanism that allows the injected mRNA to replicate within the body, akin to a viral infection. This “biological printing press” could theoretically amplify the vaccine’s presence and effects indefinitely, creating a cascade of unintended consequences that remain entirely unknown.
The clinical trial data for Kostaive is alarming, to say the least. Across phases 1, 2, and 3a, 90% of participants experienced adverse events after the first dose, with 74.5% reporting systemic reactions and 15.2% requiring medical attention. Five deaths were reported in the phase 3b study alone. These figures are not just statistics; they are human lives and health outcomes being sacrificed on the altar of expediency. Yet, despite these red flags, the CHMP has recommended approval, raising questions about the integrity of the regulatory process and the influence of pharmaceutical companies like Arcturus Therapeutics.
What is even more concerning is the lack of long-term safety data for these vaccines. As epidemiologist Nicolas Hulscher aptly noted, “These products are completely new. There is absolutely no long-term safety data on them.” The potential for these self-amplifying mRNA vaccines to transform cells, induce cancerous mutations, or trigger autoimmune responses remains unstudied. The absence of comprehensive, independent research is a glaring omission in a decision that will affect millions of lives.
Japan’s approval of the same technology in 2023, with its own troubling adverse event rates, should serve as a cautionary tale. Yet, instead of learning from these experiences, the European Union appears poised to follow suit, prioritizing the interests of Big Pharma over the well-being of its citizens. This is not just a failure of regulatory oversight; it is a betrayal of public trust.
Self-replication destroys health freedom, bodily autonomy
The implications of self-replicating mRNA vaccines extend far beyond the immediate risks to individual health. These vaccines represent a dangerous precedent in the ongoing consolidation of power by pharmaceutical corporations and captured regulatory agencies. The lack of transparency, the suppression of dissenting voices, and the disregard for genuine safety concerns are all part of a broader pattern of control that threatens health freedom and democratic governance.
Moreover, the potential for these vaccines to be used as tools for population control cannot be ignored. The ability to inject self-replicating genetic material into the human body raises ethical questions that go to the heart of what it means to be free. Once these technologies are approved, the door is opened to further experimentation, with little regard for the long-term consequences.
The European Commission must reject this recommendation and halt the approval of Kostaive and similar self-replicating mRNA vaccines. The risks far outweigh the benefits, and the lack of long-term safety data renders this technology unfit for human use. Instead of rushing to embrace untested and dangerous innovations, regulators should prioritize the health and well-being of their citizens, conducting rigorous, independent studies and ensuring that any new vaccine meets the highest standards of safety and efficacy.
As natural health professionals, we stand firm in our conviction that health freedom is a fundamental human right. The approval of self-replicating mRNA vaccines would not only jeopardize this right but also set a dangerous precedent for future medical interventions. It is time for governments and regulatory agencies to listen to the voices of scientists, health professionals, and citizens who demand transparency, accountability, and genuine protection of public health. The future of health freedom depends on it.
Sources include:
Please contact us for more information.
